157 related articles for article (PubMed ID: 14671994)
1. [Pathophysiology and clinical implication of obstructive nephropathy].
Ishidoya S; Kaneto H; Fukuzaki A; Takeda A; Ogata Y; Nakagawa H; Orikasa S; Arai Y
Nihon Hinyokika Gakkai Zasshi; 2003 Nov; 94(7):645-55. PubMed ID: 14671994
[TBL] [Abstract][Full Text] [Related]
2. Partial ureteral obstruction dysregulates the renal renin-angiotensin system in the fetal sheep kidney.
Ayan S; Roth JA; Freeman MR; Bride SH; Peters CA
Urology; 2001 Aug; 58(2):301-6. PubMed ID: 11489731
[TBL] [Abstract][Full Text] [Related]
3. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy.
Klahr S; Ishidoya S; Morrissey J
Am J Kidney Dis; 1995 Jul; 26(1):141-6. PubMed ID: 7611245
[TBL] [Abstract][Full Text] [Related]
4. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice.
Fern RJ; Yesko CM; Thornhill BA; Kim HS; Smithies O; Chevalier RL
J Clin Invest; 1999 Jan; 103(1):39-46. PubMed ID: 9884332
[TBL] [Abstract][Full Text] [Related]
5. The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy.
Miyazaki Y; Tsuchida S; Fogo A; Ichikawa I
Kidney Int; 1999 May; 55(5):1683-95. PubMed ID: 10231430
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of interstitial fibrosis in obstructive nephropathy.
Diamond JR; Ricardo SD; Klahr S
Semin Nephrol; 1998 Nov; 18(6):594-602. PubMed ID: 9819150
[TBL] [Abstract][Full Text] [Related]
7. Obstructive nephropathy: from mechanical disturbance to immune activation?
Harris KP; Klahr S; Schreiner G
Exp Nephrol; 1993; 1(3):198-204. PubMed ID: 8081970
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin II and small GTPase Ras signaling pathway inhibition on early renal changes in a murine model of obstructive nephropathy.
Rodríguez-Peña AB; Fuentes-Calvo I; Docherty NG; Arévalo M; Grande MT; Eleno N; Pérez-Barriocanal F; López-Novoa JM
Biomed Res Int; 2014; 2014():124902. PubMed ID: 25101263
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular pathophysiology of obstructive nephropathy.
Chevalier RL
Pediatr Nephrol; 1999 Sep; 13(7):612-9. PubMed ID: 10460514
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System via HuR.
Gregorini M; Corradetti V; Rocca C; Pattonieri EF; Valsania T; Milanesi S; Serpieri N; Bedino G; Esposito P; Libetta C; Avanzini MA; Mantelli M; Ingo D; Peressini S; Albertini R; Dal Canton A; Rampino T
PLoS One; 2016; 11(2):e0148542. PubMed ID: 26866372
[TBL] [Abstract][Full Text] [Related]
11. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.
Guo G; Morrissey J; McCracken R; Tolley T; Klahr S
Am J Physiol; 1999 Nov; 277(5):F766-72. PubMed ID: 10564241
[TBL] [Abstract][Full Text] [Related]
12. Obstructive uropathy.
Truong LD; Gaber L; Eknoyan G
Contrib Nephrol; 2011; 169():311-326. PubMed ID: 21252529
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.
Ma LJ; Yang H; Gaspert A; Carlesso G; Barty MM; Davidson JM; Sheppard D; Fogo AB
Am J Pathol; 2003 Oct; 163(4):1261-73. PubMed ID: 14507636
[TBL] [Abstract][Full Text] [Related]
14. The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy.
Klahr S; Morrissey JJ
Semin Nephrol; 1998 Nov; 18(6):622-32. PubMed ID: 9819153
[TBL] [Abstract][Full Text] [Related]
15. Specific molecular targeting of renal injury in obstructive nephropathy.
Chevalier RL
Kidney Int; 2006 Oct; 70(7):1200-1. PubMed ID: 16988728
[TBL] [Abstract][Full Text] [Related]
16. Obstructive nephropathy.
Klahr S
Intern Med; 2000 May; 39(5):355-61. PubMed ID: 10830173
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II and its receptors in the diabetic kidney.
Burns KD
Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
[TBL] [Abstract][Full Text] [Related]
18. Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury.
Okabe M; Miyazaki Y; Niimura F; Pastan I; Nishiyama A; Yokoo T; Ichikawa I; Matsusaka T
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F932-7. PubMed ID: 25673808
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction.
Ishidoya S; Morrissey J; McCracken R; Reyes A; Klahr S
Kidney Int; 1995 May; 47(5):1285-94. PubMed ID: 7637258
[TBL] [Abstract][Full Text] [Related]
20. Recovery following relief of unilateral ureteral obstruction in the neonatal rat.
Chevalier RL; Kim A; Thornhill BA; Wolstenholme JT
Kidney Int; 1999 Mar; 55(3):793-807. PubMed ID: 10027917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
